CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Shares withheld for taxes CEO and President gave up 6,780 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 263 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 263 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO and President gave up 4,725 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,721 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 162 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 162 shares (to pay taxes)
- 4 Open-market buy Chief Innovation/Tech Officer bought 1,000 shares at $7.78 ($7,780)
- 4 Open-market buy Chief Innovation/Tech Officer bought 2,000 shares at $8.69 ($17,380)
- 4 Open-market buy SVP-Chief Strategy/Dev Officer bought 1,000 shares at $8.00 ($8,000)
Page 14 of 17 · 326 filings